DIRS.INFO The most relevant business & tech news

☆ Regeneron expects FDA decision on higher-dose Eylea this year
▼ + stars: | 2023-08-03 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

The Regeneron Pharmaceuticals company logo is seen on a building at the company's Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File PhotoAug 3 (Reuters) - Regeneron Pharmaceuticals (REGN.O) expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the third quarter, much earlier than market expectations, sending its shares up 5% on Thursday. The U.S. Food and Drug Administration declined to approve the higher-dose version in June following an inspection at third-party manufacturer Catalent (CTLT.N). Regeneron said it has been submitting manufacturing data required by the FDA on a rolling basis, and expects to finish the submissions by mid-August. Regeneron said the higher-dose Eylea was manufactured on the same line as pozelimab, its experimental drug being reviewed to treat a rare blood disease.

Persons: Brendan McDermid, Regeneron, Wells, Mohit Bansal, Bayer, Sanofi, Khushi, Sriraj Organizations: Regeneron Pharmaceuticals, REUTERS, U.S . Food, Drug Administration, FDA, Thomson Locations: Westchester, Tarrytown , New York, U.S, Eylea, Bengaluru

A Boeing 737 MAX-10 lands over the Spirit AeroSystems logo during a flying display at the 54th International Paris Air Show at Le Bourget Airport near Paris, France, June 22, 2023. The new labor agreement will add $80 million to annual costs, Spirit said. In the second quarter, the company absorbed $28.3 million in cost related to the new labor deal as well as $7.3 million in strike disruption charges. However, the strike did impact our production and deliveries, as reflected in earnings and cash flow," Chief Executive Officer Tom Gentile said. Cash burn was $211 million for the three months through June, the company said, compared to $79 million a year earlier.

Persons: Benoit Tessier, Spirit, Tom Gentile, Cash, Refinitiv, Abhijith Ganapavaram, Valerie Insinna, Sriraj Kalluvila, Mark Porter Organizations: Boeing, International Paris Air, Le, REUTERS, International Association of Machinists, Aerospace Workers, Airbus, Revenue, Thomson Locations: Le Bourget, Paris, France, Wichita , Kansas, Wichita

REUTERS/Rick Wilking/File PhotoAug 2 (Reuters) - Industrial equipment auctioneer RB Global Inc (RBA.TO) said on Wednesday it replaced its chief executive officer, Ann Fandozzi, who recently spearheaded a $7.3 billion acquisition, amid a dispute over equity compensation. The company, formerly called Ritchie Bros Auctioneers, said Jim Kessler, its former chief operating officer and president, has been named CEO. The company gave a second-quarter earnings preview, reporting that revenue jumped 128% to $1.1 billion and net income climbed 63% to $86.8 million. The company said Fandozzi asked the board to approve a program "out of step with market standards." "My focus has been on sustaining momentum while solidifying an all-equity, at-risk incentive program to align management with long-term performance and shareholder value," she said.

Persons: Richie Bros, Rick Wilking, Ann Fandozzi, Ritchie, Auctioneers, Jim Kessler, Eric Jacobs, Jacobs, Fandozzi, Glass Lewis, Kessler, Svea Herbst, Bayliss, Pratyush Thakur, Anil D'Silva, Sriraj Kalluvila, Leslie Adler Organizations: REUTERS, Global Inc, Investors, RB Global, New York Stock Exchange, Reuters, U.S, Services, Svea, Thomson Locations: Longmont , Colorado, U.S, Boston, Bengaluru

☆ Phillips 66 joins rival refiners with sharp profit drop on lower margins
▼ + stars: | 2023-08-02 | by ( ) www.reuters.com time to read: +2 min

General view of oil tanks and the Bayway Refinery of Phillips 66 in Linden, New Jersey, U.S., March 30, 2020. Phillips said realized margins fell to $15.32 per barrel in the second quarter, from $28.62 a year earlier. Despite the fall in margins, fuel demand remains resilient. Phillips 66's crude utilization rate was 93% in the second quarter, higher than 90% a year earlier, while total processed input was unchanged year-over-year at 1.9 million barrels per day (bpd). Phillips 66's second-quarter net income fell to $1.7 billion, or $3.72 per share, from $3.2 billion, or $6.53 per share, in the year-ago quarter.

Persons: Mike Segar, Phillips, Arunima Kumar, Sriraj Organizations: Bayway, REUTERS, Rivals Valero Energy Corp, Marathon Petroleum, Thomson Locations: Phillips, Linden , New Jersey, U.S, Ukraine, Houston, Bengaluru

☆ Medical device maker Zimmer Biomet lifts profit forecast as surgeries rebound
▼ + stars: | 2023-08-01 | by ( ) www.reuters.com time to read: +1 min

Aug 1 (Reuters) - Zimmer Biomet Holdings Inc (ZBH.N) on Tuesday raised its full-year profit forecast, anticipating demand to hold up for its medical devices following a rebound in knee and hip replacement procedures. Abbott Laboratories (ABT.N) attributed its strong quarter to hospitals addressing bottlenecks from the pandemic while Johnson & Johnson (JNJ.N) said it expected to top profit estimates with surgeries bouncing back. The company now expects full-year profit of $7.47 to $7.57 per share, compared with its previous forecast of $7.40 to $7.50. The Indiana-based company's second-quarter revenue rose nearly 5% to $1.87 billion, beating analysts' estimates of $1.83 billion. Zimmer also expects reported revenue to grow between 6.5% and 7% this year, compared to its prior forecast of between 5% and 6%.

Persons: Zimmer, Johnson, Jeff Johnson, Mariam Sunny, Sriraj Organizations: Zimmer Biomet Holdings, Abbott Laboratories, Baird Equity, Thomson Locations: Indiana, Bengaluru

☆ Pfizer mulls cost cuts on volatile COVID products demand
▼ + stars: | 2023-08-01 | by ( ) www.reuters.com time to read: +2 min

Comirnaty sales declined 83% to $1.49 billion in the second quarter and antiviral treatment Paxlovid revenue tumbled 98% to $143 million. That compared with analysts' estimates of $1.40 billion for the vaccine and $1.08 billion for the pill. However, the company maintained its forecast for annual COVID revenues at about $21.5 billion. Pfizer also trimmed the upper end of its annual revenue forecast by $1 billion to $70 billion while retaining the low end at $67 billion. Total revenue for the second quarter fell 54% to $12.73 billion, compared with analysts' estimates of $13.27 billion, according to Refinitiv data.

Persons: drugmaker, Albert Bourla, Bhanvi, Sriraj Organizations: Pfizer, Thomson Locations: U.S, Bengaluru

July 31 (Reuters) - New Relic (NEWR.N) said it has agreed to be taken private by TPG (TPG.O) and Francisco Partners in a $6.5 billion all-cash deal amid stiff competition in the application performance monitoring space from rival software companies Datadog and Dynatrace. New Relic's shares rose about 13% to $83.85 on Monday following the deal involving the private equity firms. New Relic reported annual revenue growth of about 18% compared with Dynatrace's (DT.N) 25% jump. New Relic on Monday reported first-quarter revenue of $242.6 million, compared with analysts' estimates of $239.2 million, according to Refinitiv IBES data. Qatalyst Partners is the company's financial adviser, while Morgan Stanley is the lead financial adviser for Francisco Partners and TPG.

Persons: Kingsley Crane, Genuity, Jana, Morgan Stanley, Akash Sriram, Zaheer Kachwala, Sriraj Kalluvila, Shounak Organizations: TPG, Francisco Partners, Francisco, New, Jana Partners, Eminence Capital, Qatalyst, Thomson Locations: ., Bengaluru

☆ Cannabis firms Cresco, Columbia Care to terminate $2 bln merger
▼ + stars: | 2023-07-31 | by ( ) www.reuters.com time to read: +1 min

July 31 (Reuters) - Cannabis producers Cresco Labs (CL.CD) and Columbia Care Inc (CCHW.NLB) have mutually terminated their $2 billion merger announced in March last year, the companies said on Monday. "In light of the evolving landscape in the cannabis industry, we believe the decision to terminate the planned transaction is in the long-term interest of Cresco Labs and our shareholders," Cresco CEO Charles Bachtell said in a statement. Cresco and Columbia last month said they would not be able to complete the divestitures necessary to secure regulatory approvals to close the transaction. Meanwhile, Columbia Care separately said it had closed its Downtown Los Angeles facility and completed a previously announced corporate restructuring plan, including a 52-person headcount reduction. Reporting by Arshreet Singh in Bengaluru; Editing by Krishna Chandra Eluri and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Persons: Johnnie Walker, Charles Bachtell, Sean, Diddy, Combs, Arshreet Singh, Krishna Chandra Eluri Organizations: Cresco Labs, Columbia Care Inc, Columbia, Downtown, Thomson Locations: U.S, Columbia, New York , Massachusetts, Illinois, Downtown Los Angeles, Bengaluru

☆ What are global companies saying about China's economy?
▼ + stars: | 2023-07-28 | by ( ) www.reuters.com time to read: 1 min

July 28 (Reuters) - Major global firms ranging from banks to chipmakers are taking a largely cautious stance on their China business amid a frail recovery at the world's second-largest economy from a pandemic slowdown. Following are comments from firms on their China business during the latest reporting season:Reporting by Savyata Mishra and Arunima Kumar in Bengaluru; Additional reporting by Niket Nishant, Granth Vanaik, Aditya Soni and Bhanvi Satija; Editing by Sriraj Kalluvila, Eileen Soreng and Maju SamuelOur Standards: The Thomson Reuters Trust Principles.

Persons: Savyata Mishra, Arunima Kumar, Niket Nishant, Granth Vanaik, Aditya Soni, Bhanvi, Sriraj Kalluvila, Eileen Soreng, Maju Samuel Organizations: Thomson Locations: China, Bengaluru

☆ Keurig Dr Pepper beats sales estimates, posts strong forecast on higher prices
▼ + stars: | 2023-07-27 | by ( ) www.reuters.com time to read: +1 min

The results are the latest evidence that consumer companies have been largely able to pass on higher prices to retailers and shoppers. Keurig Dr Pepper posted second-quarter revenue of $3.79 billion, topping estimates of $3.69 billion, according to Refinitiv data. The company said it expects full-year 2023 net sales growth of 5% to 6%, compared with the previous forecast of a 5% growth. It reiterated its forecast for adjusted earnings per share growth of 6% to 7%. Excluding items, the company reported a profit of 42 cents per share, compared estimates of 40 cents.

Persons: Pepper, Pepper's, Dr Pepper, Bob Gamgort, Aatrayee Chatterjee, Sriraj Organizations: Pepper Inc, Thomson Locations: U.S, Texas, Bengaluru

July 27 (Reuters) - AbbVie (ABBV.N) on Thursday raised its annual profit forecast after beating analysts' estimates for second-quarter earnings on a lower-than-expected fall in sales of blockbuster arthritis drug Humira and strong sales of newer treatments. Global Humira sales tumbled 25.2% to $4.01 billion while analysts had expected $3.94 billion, according to Refinitiv data. Still, Humira sales are expected to drop 37% in 2023, and the company has been leaning on newer immunology drugs Skyrizi and Rinvoq to drive growth. Excluding one-off items, AbbVie reported a profit of $2.91 per share, beating the average analyst estimate of $2.81. The company raised its 2023 adjusted profit forecast to $10.90 to $11.10 per share from $10.57 to $10.97 earlier.

Persons: Evan Seigerman, Richard Gonzalez, Leroy Leo, Patrick Wingrove, Sriraj Kalluvila, Jonathan Oatis Organizations: Global, BMO Capital, Reuters, Thomson Locations: U.S, Amgen, Bengaluru, New York

☆ Goodyear Tire to expand board in settlement with Elliott
▼ + stars: | 2023-07-25 | by ( ) www.reuters.com time to read: +2 min

The firm urged the company to refresh the board, sell its stores and conduct an operational review. On Tuesday, Goodyear said it would establish a strategic and operational review committee. Elliott, which has a history of taking board seats at companies including Twitter and eBay, had previously criticized the tyre-manufacturer for mismanagement and lagging behind its rivals, Michelin and Bridgestone. "We have been encouraged by Goodyear's openness to taking actions necessary to realize its full potential," Elliott executives said in a statement on Tuesday. Evercore, Lazard and Goldman Sachs are financial advisers to Goodyear, while Paul Weiss the legal counsel.

Persons: Goodyear, Richard Kramer, Elliott, Lazard, Goldman Sachs, Paul Weiss, Nathan Gomes, Sriraj Organizations: Goodyear Tire &, Elliott Investment Management, Twitter, eBay, Michelin, Bridgestone, Evercore, Goodyear, Thomson Locations: Tyre, Akron , Ohio, Bengaluru

☆ Biogen to cut 1,000 jobs to save costs as Alzheimer's drug launch gathers pace
▼ + stars: | 2023-07-25 | by ( ) www.reuters.com time to read: +2 min

Investors have pinned their hopes on Leqembi as sales of multiple sclerosis drug Tecfidera take a hit from cheaper generic rivals while spinal muscular atrophy drug Spinraza faces rival treatments by Novartis (NOVN.S) and Roche (ROG.S). "Biogen's business is in transition," said CEO Christopher Viehbacher, who was hired in November to help power up growth and put behind a series of setbacks for older Alzheimer's drug Aduhelm. Multiple sclerosis treatments Avonex and Vumerity, as well as SMA therapy Spinraza, beat analyst estimates, while Tecfidera missed expectation as it faced generic rivals. "We see no unexpected surprises in Q2 results, allowing investors to focus on Alzheimer's," said Wells Fargo analyst Mohit Bansal. Reporting by Manas Mishra and Mariam Sunny in Bengaluru; Editing by Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Persons: Roche, Christopher Viehbacher, Tecfidera, Wells, Mohit Bansal, Manas Mishra, Mariam Sunny, Sriraj Organizations: Biogen, Novartis, Thomson Locations: Massachusetts, Bengaluru

☆ TC Energy to sell 40% in Columbia gas transmission systems for $4 bln
▼ + stars: | 2023-07-24 | by ( ) www.reuters.com time to read: +1 min

July 24 (Reuters) - Canada's TC Energy (TRP.TO), best known for its Keystone oil pipeline, will divest a 40% interest in its Columbia Gas Transmission and Columbia Gulf Transmission pipelines for C$5.2 billion ($3.95 billion) to Global Infrastructure Partners (GIP). TC was on course to deliver on its target to divest C$5 billion of assets by the end of the year, CEO François Poirier said in April. Columbia Gas and Columbia Gulf will be held in a new joint venture partnership and TC will remain the operator under the deal, which is expected to close in the fourth quarter. The pipelines span more than 15,000 miles and deliver a substantial portion of daily U.S. natural gas demand, including about 20% of U.S. liquefied natural gas (LNG) export supply, according to TC Energy. ($1 = 1.3180 Canadian dollars)Reporting by Arshreet Singh; Editing by Shounak Dasgupta and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Persons: François Poirier, TotalEnergies, Arshreet Singh, Shounak Dasgupta, Sriraj Organizations: Canada's TC Energy, Keystone, Columbia, Transmission, Global Infrastructure Partners, TC, Columbia Gas, GIP, TC Energy, Thomson Locations: The Calgary , Alberta, British Columbia, U.S, Rio Grande

The $100-billion company last week said lead-clad cables made up only a "small part of its network" as it sought to allay investor apprehensions. Meanwhile, New York Governor Kathy Hochul has ordered an investigation into the health risks associated with old lead-clad cables. The costs for cleaning up the lead-clad cables could "range from near-zero to tens-of-billions of dollars in liability," analysts at TD Cowen said in a July 16 note. Free cash flow is expected to be between $3.5 billion and $4 billion in the second quarter, after falling short of estimates by more than $1.5 billion in the first. Cash flow is key as it helps investors determine payouts as AT&T is one of the highest dividend paying U.S. stocks.

Persons: apprehensions, Kathy Hochul, John Stankey, Cowen, Pascal Desroches, Morningstar, Michael Hodel, Samrhitha, David Shepardson, Sriraj Organizations: Journal, Verizon, , New, Reuters, AT, Revenue, Thomson Locations: United States, ,, , New York, Refinitiv, Bengaluru, Washington

North America revenue for the current quarter will be slightly down, Chief Executive Olivier Le Peuch said in a post-earnings conference call with analysts, saying activity in the region was moderating. However, the company expects third quarter revenue from international markets to grow by a mid-single digit percentage, citing a resurgence in offshore and Middle East drilling. In comparison, last quarter's international revenue rose 21% to $6.3 billion and North America's climbed 14% to $1.75 billion. Analysts at Tudor Pickering Holt noted that international revenue missed its estimate by $1 billion, while North America slightly topped its forecast. Revenue of $8.1 billion fell slightly below analysts' estimate of $8.2 billion.

Persons: Baker Hughes, Olivier Le Peuch, America's, Tudor Pickering Holt, Peter McNally, Arathy Somasekhar, Arunima Kumar, Sriraj Kalluvila, David Holmes, Nick Zieminski Organizations: Schlumberger, Halliburton, North America, Thomson Locations: HOUSTON, America, North America, Tudor, Houston, Bengaluru

☆ J&J-spinoff Kenvue forecasts upbeat annual profit on strong self-care demand
▼ + stars: | 2023-07-20 | by ( ) www.reuters.com time to read: +2 min

Companies Kenvue Inc FollowNeutrogena Corporation FollowHaleon Plc Follow Show more companiesJuly 20 (Reuters) - Kenvue (KVUE.N), the former consumer health unit of Johnson & Johnson (JNJ.N), forecast full-year profit above Wall Street estimates on Thursday, betting on resilient demand for its skincare and self-care products such as Neutrogena and Tylenol. Kenvue, in its first results after being spun off from Johnson & Johnson in May, forecast full-year adjusted profit per share between $1.26 and $1.31. However, adjusted gross profit margin came in at 57.5%, compared to 59.3% a year earlier, dragged by a strong dollar and higher costs. Meanwhile, J&J raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its cancer drugs such as Darzalex. Net sales rose 5.4% to $4.01 billion while adjusted profit per share came in at 32 cents.

Persons: Johnson, Haleon, J, Ananya Mariam Rajesh, Raghav, Devika Syamnath Organizations: Johnson, Wall, Thomson Locations: Bengaluru

☆ Carvana shares surge on plans to cut debt load
▼ + stars: | 2023-07-19 | by ( Nathan Gomes | ) www.reuters.com time to read: +4 min

Companies Carvana Co FollowJuly 19 (Reuters) - Carvana (CVNA.N) shares soared as much as 43% on Wednesday after the troubled used-car retailer struck a deal with most of its term bondholders to cut its outstanding debt by more than $1 billion. Carvana had long-term debt of $6.54 billion as of June end, relatively unchanged from a year earlier. But Carvana has been struggling to sell cars acquired at elevated prices as buyers, hit by inflation and worried about a recession, cut spending. Carvana shares have lost 87% of their value in the past two years. In premarket trading on Wednesday, Carvana's shares rose as high as $57, in what traders said looked like a short squeeze.

Persons: John Zito, Carvana, Ernest Garcia's, Carvana's, Ortex, they're, Dennis Dick, Nathan Gomes, Bansari Mayur, Shivansh, Raechel, Medha Singh, Sriraj Kalluvila, Saumyadeb Chakrabarty, Anil D'Silva Organizations: Triple D, Carvana, Thomson Locations: Bengaluru

☆ Halliburton, Baker Hughes beats on profit as international demand offsets weak N.America
▼ + stars: | 2023-07-19 | by ( ) www.reuters.com time to read: +2 min

[1/2] The company logo of Halliburton oilfield services corporate offices is seen in Houston, Texas April 6, 2012. REUTERS/Richard Carson/File PhotoJuly 19 (Reuters) - Halliburton Co (HAL.N) and Baker Hughes (BKR.O) beat analysts' estimates for second-quarter profit on Wednesday on the back of strong demand for oilfield services internationally, even as domestic activity stumbled. Halliburton shares were down 2.1% in premarket trading at $37.30, while Baker Hughes' shares were down 3.5% at $33.98 as markets zoomed in on the first signs of weakness in North America. Halliburton, which gets nearly half its revenue from North America, said revenue from the region fell 2% to $2.7 billion, while that from international operations climbed 7% to $3.1 billion from first-quarter. Halliburton beat analysts' estimate by 2 cents at 77 cents per share for the three months ended June 30, while Baker Hughes topped estimates by 6 cents per share at 39 cents, according to Refinitiv data.

Persons: Richard Carson, Baker Hughes, Lorenzo Simonelli, Halliburton, Arathy Somasekhar, Arunima Kumar, Sourasis Bose, Sriraj Kalluvila Organizations: Halliburton, REUTERS, Thomson Locations: Houston , Texas, America, Ukraine, North America, Europe, Asia, Houston, Bengaluru

☆ Carvana enters deal to cut debt by $1.2 bln, shares surge
▼ + stars: | 2023-07-19 | by ( ) www.reuters.com time to read: +2 min

"Apollo is pleased to support this debt exchange agreement, which stands to significantly strengthen Carvana's financial position while providing creditors with new first lien debt," John Zito, Apollo's Deputy CIO of credit, said in a statement. But the company has been struggling to sell cars acquired at elevated prices as buyers hit by inflation and worried about a recession cut spending. Carvana's shares have lost 87% of its value in the past two years. The company also posted a core profit of $155 million, compared to a loss of $216 million in the year-ago quarter. Reporting by Nathan Gomes in Bengaluru; Editing by Shweta Agarwal and Sriraj KalluvilaOur Standards: The Thomson Reuters Trust Principles.

Persons: John Zito, Carvana's, Nathan Gomes, Shweta Agarwal, Sriraj Organizations: Bloomberg News, Apollo Global Management, Pacific Investment Management, Thomson Locations: Bengaluru

☆ PNC Financial's interest income forecast trim clouds upbeat quarter
▼ + stars: | 2023-07-18 | by ( ) www.reuters.com time to read: +1 min

July 18 (Reuters) - PNC Financial Services Group (PNC.N) on Tuesday cut its forecast for full-year net interest income (NII), casting a shadow over the lender's second-quarter earnings beat. The cut in full-year expectations for NII - the difference between the interest banks earn on loans and pay out on deposits - came even as PNC reported a 15% jump in NII to $3.51 billion. To lure more customers, banks are also expected to pay higher interest on deposits, a move that could increase costs and weigh on profits. PNC set aside $146 million as provisions for credit losses in the second quarter, compared to $36 million a year earlier. For the three months ended June 30, PNC earned $3.36 per share.

Persons: Niket, Sriraj Organizations: PNC Financial Services, NII, PNC, U.S . Federal Reserve, U.S, Thomson Locations: NII, Bengaluru

☆ Schwab's profit drops less than expected on asset management strength
▼ + stars: | 2023-07-18 | by ( ) www.reuters.com time to read: +2 min

Charles Schwab relies primarily on clients' uninvested cash to fund its interest-earning businesses such as purchase of fixed-income assets and lending. Schwab has had to turn to supplementary funding sources to counter this churn. Last month, the Westlake, Texas-based company said it was relying on more expensive funding sources, like borrowing from the Federal Home Loan Bank, to supplement its cash flow. Meanwhile, inflows into the company's funds boosted asset management and administration fees by 12% to $1.17 billion. Excluding one-time costs, Schwab's profit fell 25% to $1.49 billion, or 75 cents per share, for the three months ended June 30.

Persons: Charles Schwab, Schwab, Walt Bettinger, Niket, Sriraj Kalluvila, Shounak Organizations: U.S . Federal Reserve, Federal Home Loan Bank, Thomson Locations: Westlake , Texas, Bengaluru

☆ BridgeBio's heart disease drug meets late-stage study goal, shares soar
▼ + stars: | 2023-07-17 | by ( Khushi Mandowara | ) www.reuters.com time to read: +2 min

July 17 (Reuters) - BridgeBio Pharma Inc's (BBIO.O) experimental drug for a rare heart disease showed significant improvement in patients in a late-stage study, sending its shares surging 65% on Monday. BridgeBio's drug improved survival by 81% in the study patients compared to 74% on the placebo, and also reduced frequency of heart disease-related hospitalization by 50%. The California-based company also provided additional data comparing it with Pfizer's drug. Acoramidis showed 92% improvement on heart failure test, compared to patients on placebo and Pfizer's drug at 30 months. The additional data suggests that BridgeBio's drug was better than tafamidis in controlling the disease, said TD Cowen analyst Tyler Van Buren.

Persons: acoramidis, Acoramidis, Cowen, Tyler Van, Luca Issi, BridgeBio, BridgeBio's, Khushi, Nivedita Bhattacharjee Organizations: BridgeBio Pharma, Alnylam Pharmaceuticals, Ionis Pharmaceutical, RBC Capital, U.S . Food, Drug Administration, Thomson Locations: U.S, California, Tyler Van Buren, Bengaluru

SummaryCompanies JPMorgan, Wells Fargo up as Q2 profit rises on higher interest incomeUnitedHealth rises on Q2 profit beatFutures mixed: Dow adds 0.33%, S&P up 0.02%, Nasdaq slips 0.12%July 14 (Reuters) - The S&P 500 and Dow futures rose on Friday as JPMorgan Chase and Wells Fargo commenced second-quarter earnings for big U.S. banks on a strong note. UnitedHealth Group (UNH.N) gained 3.6% after the health insurer reported a quarterly profit above analysts' estimates, as the industry bellwether's expenses came in lower than feared. Overall earnings for the S&P 500 constituents are seen dropping 6.4% in the second quarter, according to Refinitiv data released at the start of the earnings season. The earnings are expected to feed into a strong rally in recent days. ET, Dow e-minis were up 114 points, or 0.33%, S&P 500 e-minis were up 1 points, or 0.02%, and Nasdaq 100 e-minis were down 19.5 points, or 0.12%.

Persons: Wells, Dow, Wells Fargo, JPMorgan Chase, Christopher Waller, bullish, Morgan, Johann M Cherian, Saumyadeb Chakrabarty Organizations: JPMorgan, Nasdaq, Dow, JPMorgan Chase, Citigroup, BlackRock, Federal, of Michigan, Dow e, Microsoft, UBS, Activision, Thomson Locations: Wells Fargo, U.S, Bengaluru

☆ Citigroup profit drops 36% as trading slump casts cloud over earnings
▼ + stars: | 2023-07-14 | by ( ) www.reuters.com time to read: +1 min

July 14 (Reuters) - Citigroup's (C.N) profit tumbled 36% in the second quarter as weakness in the Wall Street bank's trading business blunted gains from its personal banking and wealth management unit. Wall Street traders have hit a rough patch, joining investment bankers whose businesses have been weighed down for months by a slump in dealmaking. While its Wall Street operations dragged, the lender's consumer business helped partly offset some of the weakness. Revenue from its personal banking and wealth management division climbed 6% to $6.4 billion, including an 8% gain for branded cards to $2.4 billion. Net income sank to $2.92 billion, or $1.33 per share, in the three months to June 30, the bank reported on Friday.

Persons: JPMorgan Chase, Wells, Mehnaz Yasmin, Sriraj Kalluvila, Lananh Nguyen Organizations: Wall, JPMorgan, First Republic Bank, Thomson Locations: dealmaking, Bengaluru

Search resuls for: "Sriraj Kalluvila"

25 mentions found